Validity of metformin treatment in patients with polycystic ovary syndrome

Polycystic ovary syndrome (PCOS) affects 6-10% (according to the US National Institute of Health) or 20% of women (according to Rotterdam criteria) in reproductive age, becoming one of the most common endocrine disorders.

Read the entire article on farmacjapraktyczna.pl